Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 46238 [2017-21319]
Download as PDF
<![CDATA[
46238
Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices
including but not limited to releases,
discharges, satisfactions, endorsements,
assignments and deeds. Effective
October 1, 2017, the Receivership Estate
has been terminated, the receiver
discharged, and the Receivership Estate
has ceased to exist as a legal entity.
Bancorp, Inc., and thereby indirectly
acquire voting shares of Mid Penn Bank,
both in Millersburg, Pennsylvania.
Board of Governors of the Federal Reserve
System, September 29, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
Dated: September 29, 2017.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2017–21319 Filed 10–3–17; 8:45 am]
[FR Doc. 2017–21323 Filed 10–3–17; 8:45 am]
FEDERAL TRADE COMMISSION
BILLING CODE 6714–01–P
[File No. 171 0084]
FEDERAL RESERVE SYSTEM
Integra LifeSciences Holdings
Corporation and Johnson & Johnson;
Analysis To Aid Public Comment
BILLING CODE 6210–01–P
sradovich on DSK3GMQ082PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than October 30,
2017.
A. Federal Reserve Bank of
Philadelphia (William Spaniel, Senior
Vice President) 100 North 6th Street,
Philadelphia, Pennsylvania 19105–
1521. Comments can also be sent
electronically to
Comments.applications@phil.frb.org:
1. Lawrence Keister & Company,
Scottsdale, Pennsylvania; to acquire
additional voting shares of Mid Penn
VerDate Sep<11>2014
20:18 Oct 03, 2017
Jkt 244001
Federal Trade Commission.
Proposed consent agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair methods
of competition. The attached Analysis to
Aid Public Comment describes both the
allegations in the complaint and the
terms of the consent orders—embodied
in the consent agreement—that would
settle these allegations.
DATES: Comments must be received on
or before October 27, 2017.
ADDRESSES: Interested parties may file a
comment online or on paper, by
following the instructions in the
Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write: ‘‘Integra LifeSciences et
al.; FTC File No. 1710084’’ on your
comment, and file your comment online
at https://ftcpublic.commentworks.com/
ftc/integradivest by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, write ‘‘Integra LifeSciences et al.;
FTC File No. 1710084’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW., Suite CC–5610 (Annex D),
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW., 5th Floor, Suite 5610
(Annex D), Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT:
Aylin M. Skroejer, (202–326–2459),
Bureau of Competition, 600
Pennsylvania Avenue NW., Washington,
DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 6(f) of the Federal Trade
Commission Act, 15 U.S.C. 46(f), and
FTC Rule 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
consent agreement containing a consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of thirty (30) days. The following
Analysis to Aid Public Comment
describes the terms of the consent
agreement, and the allegations in the
complaint. An electronic copy of the
full text of the consent agreement
package can be obtained from the FTC
Home Page (for September 27, 2017), on
the World Wide Web, at https://
www.ftc.gov/news-events/commissionactions.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before October 27, 2017. Write ‘‘Integra
LifeSciences et al.; FTC File No.
1710084’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission Web site, at https://
www.ftc.gov/policy/public-comments.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
integradivest by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that Web
site.
If you prefer to file your comment on
paper, write ‘‘Integra LifeSciences et al.;
FTC File No. 1710084’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW., Suite CC–5610 (Annex D),
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW., 5th Floor, Suite 5610
(Annex D), Washington, DC 20024. If
possible, submit your paper comment to
the Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible FTC Web site
at https://www.ftc.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 82, Number 191 (Wednesday, October 4, 2017)]
[Notices]
[Page 46238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21319]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than October 30, 2017.
A. Federal Reserve Bank of Philadelphia (William Spaniel, Senior
Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105-
1521. Comments can also be sent electronically to
Comments.applications@phil.frb.org:
1. Lawrence Keister & Company, Scottsdale, Pennsylvania; to acquire
additional voting shares of Mid Penn Bancorp, Inc., and thereby
indirectly acquire voting shares of Mid Penn Bank, both in Millersburg,
Pennsylvania.
Board of Governors of the Federal Reserve System, September 29,
2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017-21319 Filed 10-3-17; 8:45 am]
BILLING CODE 6210-01-P
